OverviewSuggest Edit

Universal Biosensors (UBI) is focused on the research, development, and manufacture of diagnostic test systems for point-of-care (POC) professional and home use. UBI’s core technology is a disposable, multi-layer test strip, which incorporates a proprietary electrochemical sensing system that rapidly and accurately measures biomarkers in the blood. This technology offers speed, ease of use, reliability, and accuracy at a low cost.

TypePublic
Founded2001
HQRowville, AU
Websiteuniversalbiosensors.com

Latest Updates

Employees (est.) (Jul 2021)60
Revenue (FY, 2020)$3.2 M(-53%)
Share Price (Sept 2021)$0.9(+5%)
Cybersecurity ratingBMore

Key People/Management at Universal Biosensors

Craig Coleman

Craig Coleman

Non-Executive Chairman
John Sharman

John Sharman

CEO
Salesh Balak

Salesh Balak

CFO
Marshall Heinberg

Marshall Heinberg

Non-Executive Director
Judith Smith

Judith Smith

Non-Executive Director
David Hoey

David Hoey

Non-Executive Director
Show more

Universal Biosensors Office Locations

Universal Biosensors has an office in Rowville
Rowville, AU (HQ)
1 Corporate Ave
Show all (1)

Universal Biosensors Financials and Metrics

Universal Biosensors Revenue

Embed Graph
View revenue for all periods
Universal Biosensors's revenue was reported to be $3.2 m in FY, 2020
AUD

Revenue (Q1, 2021)

1.5m

Gross profit (Q1, 2021)

710.5k

Gross profit margin (Q1, 2021), %

45.9%

Net income (Q1, 2021)

(1.4m)

EBIT (Q1, 2021)

(2.4m)

Market capitalization (9-Sept-2021)

146.5m

Closing stock price (9-Sept-2021)

0.9

Cash (31-Mar-2021)

20.7m

EV

126.5m
Universal Biosensors's current market capitalization is $146.5 m.
Annual
AUDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

14.7m29.6m15.1m9.5m16.8m18.8m25.2m69.9m6.9m3.2m

Revenue growth, %

(37%)76%12%

Cost of goods sold

12.3m18.0m10.5m555.8k1.4m1.2m4.0m2.5m3.6m2.6m

Gross profit

2.4m11.7m4.6m9.0m15.4m17.7m21.2m67.4m3.3m623.1k
AUDQ2, 2011

Financial Leverage

1.1 x
Show all financial metrics

Universal Biosensors Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

Universal Biosensors Online and Social Media Presence

Embed Graph

Universal Biosensors News and Updates

Medical Biosensors Market Explore Future Growth 2016-2022 by Global Top Players - Universal Biosensors, Bayer, Abbott Point of Care, LIFESCAN, Sysmex, Pharmaco-Kinesis, Medtronic, LASX, Novartis, LifeSensors, SIEMENS, GE Healthcare, Nova Biomedical, Honey

Worldwide Market Reports has announced the addition of the “Global Medical Biosensors Market Professional Survey Report 2017”, The report classifies the global Projection Mapping Equipment Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as r…

Universal Biosensors Frequently Asked Questions

  • When was Universal Biosensors founded?

    Universal Biosensors was founded in 2001.

  • Who are Universal Biosensors key executives?

    Universal Biosensors's key executives are Craig Coleman, John Sharman and Salesh Balak.

  • How many employees does Universal Biosensors have?

    Universal Biosensors has 60 employees.

  • What is Universal Biosensors revenue?

    Latest Universal Biosensors annual revenue is $3.2 m.

  • What is Universal Biosensors revenue per employee?

    Latest Universal Biosensors revenue per employee is $53.4 k.

  • Who are Universal Biosensors competitors?

    Competitors of Universal Biosensors include Diatherix, NeuMoDx and BioVendor.

  • Where is Universal Biosensors headquarters?

    Universal Biosensors headquarters is located at 1 Corporate Ave, Rowville.

  • Where are Universal Biosensors offices?

    Universal Biosensors has an office in Rowville.

  • How many offices does Universal Biosensors have?

    Universal Biosensors has 1 office.